tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Boobalan Pachaiyappan, 31 are a BUY (100%).
Analyst Boobalan Pachaiyappan, currently employed at ROTH, carries an average stock price target met ratio of 21.96% that have a potential upside of 45.76% achieved within 97 days. Previously, Boobalan Pachaiyappan worked at ROTH MKM.
Boobalan Pachaiyappan’s has documented 61 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ANVS, Annovis Bio at 28-Aug-2026.
Analyst best performing recommendations are on CAPR (CAPRICOR THERAPEUTICS).
The best stock recommendation documented was for CAPR (CAPRICOR THERAPEUTICS) at 11/12/2025. The price target of $13 was fulfilled within 21 days with a profit of $7.13 (121.47%) receiving and performance score of 57.84.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 14-Sep-2026
$21
$12.05 (134.64%)
24 days ago
(14-Sep-2026)
1/4 (25%)
$12.19 (138.37%)
160
Hold Since 01-Sep-2026
$25
$16.05 (179.33%)
1 months 7 days ago
(01-Sep-2026)
2/6 (33.33%)
$14.99 (149.75%)
520
Hold Since 14-Aug-2026
$28
$19.05 (212.85%)
1 months 24 days ago
(14-Aug-2026)
8/9 (88.89%)
$21.35 (321.05%)
217
Buy Since 18-Nov-2024
$51
2 months 7 days ago
(31-Jul-2026)
0/3 (0%)
$21.04 (70.23%)
Buy Since 15-Jul-2019
$60
2 months 8 days ago
(30-Jul-2026)
10/18 (55.56%)
$29.5 (96.72%)
536
Which stock is Boobalan Pachaiyappan most bullish on?
Which stock is Boobalan Pachaiyappan most reserved on?
What Year was the first public recommendation made by Boobalan Pachaiyappan?
